Rabies
📧 Sign up to get email alerts when something new happens for Rabies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally [Phase 4]
Phase 4 trial update on safety and immunogenicity of the inactivated rabies vaccine RABIVAX-S given intramuscularly and intradermally.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Responses to Rabies Vaccine in Adults With or Without Antibiotics [Phase 4]
Phase 4 trial evaluating responses to rabies vaccine in adults with or without antibiotics has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety [Phase 3]
Phase III clinical study assessing SYN023 for rabies has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine [Phase 4]
A Phase 4 trial reports observation on immune persistence after vaccination with five doses of a rabies vaccine in people aged 10–60 years.
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine [Phase 4]
Phase 4 trial assessing immunogenicity and safety when coadministering the inactivated SARS-CoV-2 vaccine BBIBP-CorV with the rabies vaccine…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis [Phase 4]
Phase 4 trial update on the immunogenicity of a rabies vaccine for pre-exposure prophylaxis; results completed and posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen [Phase 3]
Phase 3 trial update assessing immunogenicity and safety of Verorab in a one-week intradermal post-exposure prophylaxis regimen for rabies.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults [Phase 3]
Phase 3 trial comparing Purified Vero Rabies Vaccine with two reference rabies vaccines in a simulated post-exposure regimen in adults; resu…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects [Phase 2, Phase 3]
Phase II/III trial assessing the safety and effectiveness of HRIG with active rabies vaccine in healthy subjects has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies [Phase 3]
A Phase 3 post-marketing study evaluating KamRAB given as a single dose with active rabies vaccine in children exposed to rabies has complet…
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. [Phase 4]
A Phase 4 clinical trial evaluating the effect of antimalarial drugs on rabies vaccine for post-exposure prophylaxis has completed, with res…
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Immunogenicity and Safety of a Purified Vero Rabies Vaccine [Phase 2]
Phase 2 trial update on immunogenicity and safety of a purified Vero Rabies vaccine.
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Safety of Rabivax-S for Pre-exposure Prophylaxis [Phase 4]
A Phase 4 trial update assessing the safety of Rabivax-S for pre-exposure prophylaxis, completed.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine . [Phase 3]
Phase 3 trial update reporting immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine; study completed.
-
CLINICAL_TRIALS trial_result · 2019-03-06Clinical Trial Update: Simplifying the Rabies Pre-exposure Vaccination [Phase 3]
Phase 3 trial update on simplifying the rabies pre-exposure vaccination regimen.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating safety, pharmacodynamics, and pharmacokinetics of a single dose of SYN023 with licensed rabies va…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults [Phase 1]
Phase 1 study assessing the safety and tolerability of CV8102 alone and in combination with a rabies virus vaccine in healthy adults.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response [NA]
A completed clinical study evaluating the dosing of human rabies immunoglobulin (HRIG) and its effect on the development of an active immune…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIG [Phase 4]
A Phase 4 clinical trial evaluated the immunogenicity and safety of a chromatographically purified Vero cell rabies vaccine given with an in…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins [NA]
This clinical trial evaluated the immunogenicity of a reduced four-dose rabies vaccine schedule with rabies immunoglobulin.
-
CLINICAL_TRIALS trial_result · 2018-02-09Clinical Trial Update: Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use [Phase 2]
Phase 2 trial comparing purified Vero Rabies Vaccine, serum-free, with human diploid cell vaccine for pre-exposure use in rabies.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen [Phase 2]
Two vaccines were compared in a Phase 2 pre-exposure rabies prophylaxis trial and the study has completed. The trial was sponsored by Sanofi…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children [Phase 4]
A Phase 4 clinical trial update evaluating the durability of immune responses after post-exposure prophylaxis with Rabipur rabies vaccine in…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age [Phase 3]
Phase 3 trial assesses safety and immunogenicity of two intradermal rabies vaccine regimens administered with or without human rabies immuno…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients [NA]
A completed clinical trial assessed whether rabies immunoglobulin influences the immunogenicity of post-exposure rabies vaccination in obese…